Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member Expression

McCubrey, James A.2022-02-042022-02-042017-12-061949-2553http://hdl.handle.net/10342/9628en-USdrug transportersMEK1cancer stem cellsDrug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-Family Member ExpressionArticle10.18632/oncotarget.22956